New heart valve clip could spare patients from Open-Heart surgery
NCT ID NCT07433504
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a new device that clips together the leaflets of a leaky tricuspid valve, aiming to fix it without open-heart surgery. It will enroll 132 people with severe tricuspid regurgitation who are already on standard medications. The study compares the clip plus medication to medication alone, tracking deaths, reoperations, hospital readmissions, and symptom improvement over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcatheter tricuspid valve clipping system
- What this could lead to
- If successful, this could offer a less invasive treatment option for people with severe tricuspid regurgitation, potentially reducing symptoms and hospital stays.
- What could go wrong
- This is an early-stage trial with only 132 participants, so results may not apply to everyone. The procedure carries risks like bleeding, infection, or device complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE OR GREATER TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, China